Back to Search Start Over

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 (Y-90) Ibritumomab Tiuxetan (Y-90-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3686..11fd9213f3bdbf34048da5d64ca80dcb